Everence Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
1,278
+388
+44% +$97.5K 0.02% 636
2025
Q4
$253K Sell
890
-1,698
-66% -$531K 0.02% 659
2025
Q3
$799K Buy
2,588
+928
+56% +$291K 0.05% 281
2025
Q2
$522K Sell
1,660
-460
-22% -$133K 0.03% 365
2025
Q1
$557K Buy
2,120
+1,070
+102% +$290K 0.04% 341
2024
Q4
$274K Buy
+1,050
New +$264K 0.02% 624

Other funds holding PODD

Everence Capital Management's PODD Position: Q1 2026 in Review

Everence Capital Management increased its Insulet (PODD) stake by 44% in Q1 2026, buying an estimated $97.5K and bringing the position to 1,278 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #636.

Everence Capital Management first reported a position in PODD in Q4 2024 and has held it in 6 quarters since. The position peaked at $799K in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Everence Capital Management held 1,278 shares of Insulet worth $268K as of Q1 2026.
  • Everence Capital Management bought 388 Insulet shares in Q1 2026, an estimated $97.5K.
  • Insulet made up 0.02% of Everence Capital Management's portfolio in Q1 2026, its #636 holding.
  • Everence Capital Management first reported a position in Insulet in Q4 2024 and has held it in 6 quarters since.
  • Everence Capital Management's Insulet position peaked at $799K in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.